West-Ward Pharmaceutical Corp

General

Total Cases34

Active Cases--

Patents--

CourtsD. Delaware D. New Jersey D. Nevada

TypeOperating Company

Elite Ratings

DCT

Ratings

Experience

Grade

Trend

DCT

L4

B

PTAB

L5

D

CAFC

--

--

--

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered	Case	Description
12/31/24	Amarin Pharma Inc v. Hikma Pharmaceuticals USA Inc 2:16-CV-02525 ( D. NV )	MINUTE ORDER IN CHAMBERS of the Honorable Judge Miranda M. Du on 12/31/2024. Before the Court is Amarin's motion to unseal an exhibit to one of its motions consistent with the Court's prior order (ECF No. [440] ). Good cause appearing, the motion is granted. The Clerk of Court is directed to replace ECF No. 423 -4 with ECF No. [440] -1. (no image attached) (Copies have been distributed pursuant to the NEF - KW) (Entered: 12/31/2024) MINUTE ORDER IN CHAMBERS of the Honorable Judge Miranda M. Du on 12/31/2024. Before the Court is Amarin's motion to unseal an exhibit to one of its motions consistent with the Court's prior order (ECF No. [440] ). Good cause appearing, the motion is granted. The Clerk of Court is directed to replace ECF No. 423 -4 with ECF No. [440] -1. (no image attached) (Copies have been distributed pursuant to the NEF - KW) (Entered: 12/31/2024)
12/31/24	Amarin Pharma Inc v. Hikma Pharmaceuticals USA Inc 2:16-CV-02525 ( D. NV )	MINUTE ORDER IN CHAMBERS of the Honorable Judge Miranda M. Du on 12/31/2024. Before the Court is Amarin's motion to unseal an exhibit to one of its motions consistent with the Court's prior order (ECF No. [440] ). Good cause appearing, the motion is granted. The Clerk of Court is directed to replace ECF No. 423 -4 with ECF No. [440] -1. (no image attached) (Copies have been distributed pursuant to the NEF - KW) (Entered: 12/31/2024) MINUTE ORDER IN CHAMBERS of the Honorable Judge Miranda M. Du on 12/31/2024. Before the Court is Amarin's motion to unseal an exhibit to one of its motions consistent with the Court's prior order (ECF No. [440] ). Good cause appearing, the motion is granted. The Clerk of Court is directed to replace ECF No. 423 -4 with ECF No. [440] -1. (no image attached) (Copies have been distributed pursuant to the NEF - KW) (Entered: 12/31/2024)
12/23/24	Amarin Pharma Inc v. Hikma Pharmaceuticals USA Inc 2:16-CV-02525 ( D. NV )	MOTION to Unseal Document by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited. Responses due by 1/6/2025. (Attachments: # [1] Exhibit A)(Hosmer-Henner, Adam) (Entered: 12/23/2024)
12/23/24	Amarin Pharma Inc v. Hikma Pharmaceuticals USA Inc 2:16-CV-02525 ( D. NV )	MOTION to Unseal Document by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited. Responses due by 1/6/2025. (Attachments: # [1] Exhibit A)(Hosmer-Henner, Adam) (Entered: 12/23/2024)
12/06/24	Amarin Pharma Inc v. Hikma Pharmaceuticals USA Inc 2:16-CV-02525 ( D. NV )	REDACTED Version of document as to [438] Order on Motion to Enforce,,,,,,,, Order on Motion to Seal,,,,,,,,,,,,,,, Defendant's Opposition to Plaintiffs' Motion to Enforce the Settlement Agreement by Defendant Teva Pharmaceutical Industries Limited. (Pisanelli, James) (Entered: 12/06/2024)
12/06/24	Amarin Pharma Inc v. Hikma Pharmaceuticals USA Inc 2:16-CV-02525 ( D. NV )	REDACTED Version of document as to [438] Order on Motion to Enforce,,,,,,,, Order on Motion to Seal,,,,,,,,,,,,,,, Defendant's Opposition to Plaintiffs' Motion to Enforce the Settlement Agreement by Defendant Teva Pharmaceutical Industries Limited. (Pisanelli, James) (Entered: 12/06/2024)
12/04/24	Amarin Pharma Inc v. Hikma Pharmaceuticals USA Inc 2:16-CV-02525 ( D. NV )	ORDER. It is therefore ordered that Plaintiffs motion to enforce the settlement agreement ECF Nos. [422] , 423 is denied as specified herein. The Clerk of Court is directed to unseal the versions of the Motion and reply filed with redactions. ECF Nos. [422] , [435] . It is further ordered that both sides motions to seal ECF Nos. [424] , [430] , [437] are granted. The other documents filed under seal will accordingly remain under seal. It is further ordered that Teva must file a version of its response filed under seal ECF No. 429 with confidential excerpts of the settlement agreement redacted within days, so that there is a public record of the arguments Teva raised in response to the Motion. Signed by Judge Miranda M. Du on 12/3/2024. (Copies have been distributed pursuant to the NEF - CAH) (Entered: 12/04/2024) ORDER. It is therefore ordered that Plaintiffs motion to enforce the settlement agreement ECF Nos. [422] , 423 is denied as specified herein. The Clerk of Court is directed to unseal the versions of the Motion and reply filed with redactions. ECF Nos. [422] , [435] . It is further ordered that both sides motions to seal ECF Nos. [424] , [430] , [437] are granted. The other documents filed under seal will accordingly remain under seal. It is further ordered that Teva must file a version of its response filed under seal ECF No. 429 with confidential excerpts of the settlement agreement redacted within days, so that there is a public record of the arguments Teva raised in response to the Motion. Signed by Judge Miranda M. Du on 12/3/2024. (Copies have been distributed pursuant to the NEF - CAH) (Entered: 12/04/2024)
12/04/24	Amarin Pharma Inc v. Hikma Pharmaceuticals USA Inc 2:16-CV-02525 ( D. NV )	ORDER. It is therefore ordered that Plaintiffs motion to enforce the settlement agreement ECF Nos. [422] , 423 is denied as specified herein. The Clerk of Court is directed to unseal the versions of the Motion and reply filed with redactions. ECF Nos. [422] , [435] . It is further ordered that both sides motions to seal ECF Nos. [424] , [430] , [437] are granted. The other documents filed under seal will accordingly remain under seal. It is further ordered that Teva must file a version of its response filed under seal ECF No. 429 with confidential excerpts of the settlement agreement redacted within days, so that there is a public record of the arguments Teva raised in response to the Motion. Signed by Judge Miranda M. Du on 12/3/2024. (Copies have been distributed pursuant to the NEF - CAH) (Entered: 12/04/2024) ORDER. It is therefore ordered that Plaintiffs motion to enforce the settlement agreement ECF Nos. [422] , 423 is denied as specified herein. The Clerk of Court is directed to unseal the versions of the Motion and reply filed with redactions. ECF Nos. [422] , [435] . It is further ordered that both sides motions to seal ECF Nos. [424] , [430] , [437] are granted. The other documents filed under seal will accordingly remain under seal. It is further ordered that Teva must file a version of its response filed under seal ECF No. 429 with confidential excerpts of the settlement agreement redacted within days, so that there is a public record of the arguments Teva raised in response to the Motion. Signed by Judge Miranda M. Du on 12/3/2024. (Copies have been distributed pursuant to the NEF - CAH) (Entered: 12/04/2024)
06/14/24	Amarin Pharma Inc v. Hikma Pharmaceuticals USA Inc 2:16-CV-02525 ( D. NV )	MOTION to Seal Document by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited, Counter Defendants Amarin Pharma, Inc., Amarin Pharma, Inc., Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited, Amarin Pharmaceuticals Ireland Limited, Amarin Pharmaceuticals Ireland Limited. Responses due by 6/28/2024. (Attachments: # [1] Exhibit A)(Hosmer-Henner, Adam) (Entered: 06/14/2024) MOTION to Seal Document by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited, Counter Defendants Amarin Pharma, Inc., Amarin Pharma, Inc., Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited, Amarin Pharmaceuticals Ireland Limited, Amarin Pharmaceuticals Ireland Limited. Responses due by 6/28/2024. (Attachments: # [1] Exhibit A)(Hosmer-Henner, Adam) (Entered: 06/14/2024)
06/14/24	Amarin Pharma Inc v. Hikma Pharmaceuticals USA Inc 2:16-CV-02525 ( D. NV )	MOTION to Seal Document by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited, Counter Defendants Amarin Pharma, Inc., Amarin Pharma, Inc., Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited, Amarin Pharmaceuticals Ireland Limited, Amarin Pharmaceuticals Ireland Limited. Responses due by 6/28/2024. (Attachments: # [1] Exhibit A)(Hosmer-Henner, Adam) (Entered: 06/14/2024) MOTION to Seal Document by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited, Counter Defendants Amarin Pharma, Inc., Amarin Pharma, Inc., Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited, Amarin Pharmaceuticals Ireland Limited, Amarin Pharmaceuticals Ireland Limited. Responses due by 6/28/2024. (Attachments: # [1] Exhibit A)(Hosmer-Henner, Adam) (Entered: 06/14/2024)